5 completed, 2 withdrawn, 1 terminated. 6 Phase 2, 2 Phase 1, 1 Phase 3.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 6 | Completed 3, Withdrawn 2, Terminated 1 |
| Phase 1 | 2 | Completed 2 |
| Phase 3 | 1 | Withdrawn 1 |
Follow Archivel Farma S.L.: new trials by email
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Safety and Efficacy of RUTI® With the Standard of Treatment for Tuberculosis RUTI® Vaccine, Placebo - Tuberculosis, Pulmonary | Phase 2 | Completed | Archivel Farma S.L. | 41 | 2022-10-29 | 2025-12-10 |
| A Clinical Trial to Evaluate the Efficacy of RUTI® to Reduce the Severity of SARS-CoV-2 Infection (COVID-19) RUTI® vaccine, Placebo - COVID-19 | Phase 2 / Phase 3 | Withdrawn | PT. Innovative Pharma Solutions | 2021-12-01 | 2023-02-10 | |
| Evaluation of Efficacy and Safety of the Concomitant of RUTI® Immunotherapy With the Standard Treatment in TB Patients RUTI® vaccine, Placebo - Tuberculosis | Phase 2 | Withdrawn | Archivel Farma S.L. | 2021-12-01 | 2022-07-13 | |
| Clinical Trial to Investigate Therapeutic Vaccine (RUTI) Against Tuberculosis (TB) RUTI®, Placebo - Tuberculosis, Pulmonary | Phase 2 | Completed | Archivel Farma S.L. | 140 | 2021-09-22 | 2025-12-10 |
| Safety of RUTI® Vaccination in MDR-TB Patients RUTI® Therapeutic vaccine, Matching RUTI® Placebo - Tuberculosis, Multidrug Resistant | Phase 2 | Terminated | Archivel Farma S.L. | 9 | 2020-03-18 | 2022-07-05 |
| Immunological Response to Intravesical BCG Therapy of Superficial Bladder Cancer by Prior Administration of RUTI® RUTI®, Placebo - High-Risk Non-Muscle-Invasive Bladder Cancer | Phase 1 | Completed | Archivel Farma S.L. | 44 | 2017-06-16 | 2023-07-14 |
| Clinical Trial to Investigate the Safety, Tolerability, and Immunogenicity of the Novel Antituberculous Vaccine RUTI® Following One Month of Isoniazid Treatment in Subjects With Latent Tuberculosis Infection RUTI, RUTI Matching Placebo - Latent Tuberculosis Infection, Tuberculosis | Phase 2 | Completed | Archivel Farma S.L. | 95 | 2010-06-01 | 2013-01-24 |
| Clinical Trial to Study 4 Different Doses of the Vaccine RUTI in Healthy Volunteers RUTI, placebo of the vaccine RUTI - Latent Tuberculosis Infection, Tuberculosis | Phase 1 | Completed | Germans Trias i Pujol Hospital | 24 | 2007-04-01 | 2009-05-27 |
Tuberculosis (4) · Latent Tuberculosis (2) · Tuberculosis, Pulmonary (2) · COVID-19 (1) · Non-Muscle Invasive Bladder Neoplasms (1) · Tuberculosis, Multidrug-Resistant (1)
Spain (2) · Argentina (1) · India (1) · South Africa (1) · Ukraine (1)
Joan Costa, MD, PhD (1) · Pere Joan Cardona, MD, PhD (1) · Pere-Joan Cardona, MD, PhD (1) · Randeep Guleria, Prof (1)
2016 (1)